dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
Published 4 years ago • 227 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
0:54
activity of dabrafenib/trametinib combo in patients with melanoma brain metastases
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
1:04
dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
2:11
dr. georgina long on dabrafenib and trametinib in braf-mutated melanoma
-
6:43
managing brain metastases in melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
5:26
updates in melanoma: treating braf and brain metastases
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
1:24
dr. algazi on benefit of continuous dabrafenib/trametinib dosing in braf melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
1:33
dr. robert on next steps following the phase iii combi-v study in melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
1:46
dr. glitza olivia on the prognosis of melanoma brain metastases
-
0:55
dr. sheri holmen on brain metastases in melanoma
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma